0001554851-17-000004.txt : 20170201 0001554851-17-000004.hdr.sgml : 20170201 20170201162628 ACCESSION NUMBER: 0001554851-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170201 DATE AS OF CHANGE: 20170201 EFFECTIVENESS DATE: 20170201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allurion Technologies, Inc. CENTRAL INDEX KEY: 0001554851 IRS NUMBER: 271843492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-279829 FILM NUMBER: 17565237 BUSINESS ADDRESS: STREET 1: 14 HURON DRIVE CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: (617) 721-0406 MAIL ADDRESS: STREET 1: 14 HURON DRIVE CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0707 D LIVE 0001554851 Allurion Technologies, Inc. 14 HURON DRIVE NATICK MA MASSACHUSETTS 01760 781-235-7050 ext 20 DELAWARE SGL Medical, Inc. None Corporation true Shantanu K Gaur c/o Allurion Technologies, Inc. 14 Huron Drive Natick MA MASSACHUSETTS 01760 Executive Officer Director Samuel G Levy c/o Allurion Technologies, Inc. 14 Huron Drive Natick MA MASSACHUSETTS 01760 Executive Officer Director Mr. Levy is a consultant to the company. Jonathan D Wecker c/o Allurion Technologies, Inc. 14 Huron Drive Natick MA MASSACHUSETTS 01760 Executive Officer Director Neil Chheda c/o Romulus Capital 151 Tremont St., Suite 6F Boston MA MASSACHUSETTS 02111 Director Krishna Gupta c/o Romulus Capital. 151 Tremont St., Suite 6F Boston MA MASSACHUSETTS 02111 Director Other Health Care Decline to Disclose 06b false 2017-01-17 false true false 0 27307000 19020678 8286322 A portion of the total amount sold in item 13 includes conversion of promissory notes. Amount sold shown in item 13 and number of investors in item 14 include $1,087,558 from three non-US investors. false 45 0 0 0 false Allurion Technologies, Inc. /s/Jonathan D. Wecker Jonathan D. Wecker CEO 2017-02-01